SEC 13F Intelligence

Bi Asset Management Fondsmaeglerselskab A/S / VRTX

Bi Asset Management Fondsmaeglerselskab A/S’s Vertex Pharmaceuticals Inc Position

Does Bi Asset Management Fondsmaeglerselskab A/S own Vertex Pharmaceuticals Inc (VRTX)? Yes — 49.5K shares worth $22M (+0.23% of its 13F portfolio) as of Q1 2026, up from 10.5K shares the prior filed quarter.

Position Value
$22M
Q1 2026
Shares
49.5K
% of Portfolio
+0.23%
Quarters Held
25
currently held

Position History VRTX

Reported value by quarter
Q1 ’20: $1MQ1 ’20Q2 ’20: $5MQ3 ’20: $6MQ4 ’20: $13MQ1 ’21: $13MQ1 ’21Q2 ’21: $11MQ3 ’21: $14MQ4 ’21: $17MQ1 ’22: $18MQ1 ’22Q2 ’22: $15MQ3 ’22: $13MQ4 ’22: $14MQ1 ’23: $18MQ1 ’23Q2 ’23: $18MQ3 ’23: $22MQ4 ’23: $24MQ1 ’24: $29MQ1 ’24Q2 ’24: $28MQ3 ’24: $9MQ4 ’24: $7MQ1 ’25: $6MQ1 ’25Q2 ’25: $6MQ3 ’25: $4MQ4 ’25: $5MQ1 ’26: $22MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202649.5K$22M+0.23%
Q4 202510.5K$5M+0.04%
Q3 202510.6K$4M+0.04%
Q2 202513.7K$6M+0.06%
Q1 202511.7K$6M+0.06%
Q4 202416.3K$7M+0.07%
Q3 202419.8K$9M+0.16%
Q2 202459.5K$28M+0.46%
Q1 202468.5K$29M+0.54%
Q4 202358.1K$24M+0.50%
Q3 202361.9K$22M+0.50%
Q2 202351.2K$18M+0.43%
Q1 202356.3K$18M+0.47%
Q4 202250.0K$14M+0.38%
Q3 202246.3K$13M+0.68%
Q2 202253.8K$15M+0.65%
Q1 202269.0K$18M+0.69%
Q4 202178.9K$17M+0.64%
Q3 202179.3K$14M+0.54%
Q2 202155.7K$11M+0.43%
Q1 202161.1K$13M+0.53%
Q4 202054.3K$13M+0.56%
Q3 202023.8K$6M+0.29%
Q2 202018.0K$5M+0.27%
Q1 20205.9K$1M+0.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bi Asset Management Fondsmaeglerselskab A/S’s full portfolio or all institutional holders of VRTX.